BioAge Labs, Inc. — Director's Dealing 2024

Sep 25, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BioAge Labs, Inc. (BIOA)
CIK: 0001709941
Period of Report: 2024-09-25

Reporting Person: Barton Shane (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$10.85	2033-09-26	Common Stock (26890)		Direct
Stock Option (Right to Buy)	$8.39	2034-04-16	Common Stock (28277)		Direct

Footnotes

F1: The option vested as to 1/4th of the total award on September 25, 2024, and thereafter shall vest as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

F2: The option shall vest as to 1/48th of the total award monthly, with the first tranche vesting on October 17, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.